Oncology (RKI_009)
About Study Course
Objective
To provide students with and improve their theoretical knowledge and practical skills in oncology in accordance with the requirements of the surgery speciality regulations in order to prepare the doctor for certification in surgeon’s speciality.
Learning outcomes
1.- tumour epidemiology, trends in the world and in Latvia;
- tumour epidemiology;
- diagnostic screening of malignant tumours;
- basic principles of tumour therapy (neoadjuvant, adjuvant) and ways and results of practical application of treatment;
- principles of health survey and registration of patients in Latvia;
- to be able to act in case of providing emergency medical assistance in oncology;
- possibilities and implementation of palliative therapy in oncology;
- documentation of an oncological patient;
- principles of medical ethics in oncology.
1.- to evaluate population groups at higher risk in oncology,
- to evaluate a specific risk in case of individual tumour localisations;
- to plan necessary examinations for screening, diagnostics and staging of different malignant tumours;
- to interpret results of clinical analyses, radiological and endoscopic examinations;
- to obtain tissue material for cytological and histological examination, to prepare respective accompanying documents and to evaluate results of morphological examinations;
- to perform puncture of the pleural cavity and ascites;
- to perform digital rectal examination and to evaluate its results;
- to organise necessary medical assistance for an oncological patient in case of acute situations;
- to prescribe an adequate analgesic and palliative therapy in case of tumours;
- to adequately examine a patient with potential oncological pathology, to organise the patient monitoring process after radical treatment (health survey) for diagnostics of a recurrence in a timely manner;
- to work with oncological patients and medical facility personnel, observing principles of medical ethics.
1.To deliver skillful first and emergency medical assistance to patients with oncological pathology.
